Comera Life Sciences Holdings, Inc.
CMRAOTCHealthcare● Active
$0.00
+$0.00(+9900.00%)
Market Cap$3074
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Comera Life Sciences Holdings, Inc.（CMRA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CMRA · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $0.63M | $0.32M | $0.44M |
| Cost of Revenue | $0.21M | $0.16M | $0.10M |
| Gross Profit | $0.42M | $0.16M | $0.34M |
| Gross Margin %(computed) | 66.77% | 49.66% | 76.43% |
| Operating Expenses | |||
| R&D Expenses | $1.74M | $1.75M | $1.26M |
| G&A Expenses | $10.65M | $3.94M | $1.20M |
| Total Operating Expenses | $12.39M | $5.69M | $2.47M |
| Operating Income | ($11.97M) | ($5.54M) | ($2.13M) |
| Operating Margin %(computed) | — | — | -480.34% |
| Interest Income | $0.00M | $0.00M | $0.01M |
| Interest Expense | $0.02M | $0.00M | $0.00M |
| Income Before Tax | ($18.00M) | ($5.45M) | ($2.13M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M |
| Net Income | ($18.00M) | ($5.45M) | ($2.13M) |
| Net Margin %(computed) | — | — | -479.88% |
| Per Share & EBITDA | |||
| EPS (Basic) | $-1.76 | $-0.29 | $-0.11 |
| Wtd Avg Shares | 10.45M | 19.09M | 19.09M |
| EBITDA | ($17.89M) | ($5.37M) | ($2.04M) |
| EBITDA Margin %(computed) | — | — | -460.08% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Comera Life Sciences Holdings, Inc.
关于Comera Life Sciences Holdings, Inc.（CMRA）损益表
Comera Life Sciences Holdings, Inc.（CMRA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，CMRA实现营收$0.00B，毛利润$0.00B（毛利率66.77%），净利润($0.02B)（净利率-2843.79%）。
常见问题
CMRA · 4 问Comera Life Sciences Holdings, Inc.（CMRA）2022财年营收为$0.00B，同比up97.9%。
CMRA revenueCMRA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09